rs139640415

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003748.4(ALDH4A1):​c.413C>T​(p.Pro138Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0024 in 1,542,014 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P138P) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0024 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0024 ( 4 hom. )

Consequence

ALDH4A1
NM_003748.4 missense

Scores

7
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 6.21

Publications

5 publications found
Variant links:
Genes affected
ALDH4A1 (HGNC:406): (aldehyde dehydrogenase 4 family member A1) This protein belongs to the aldehyde dehydrogenase family of proteins. This enzyme is a mitochondrial matrix NAD-dependent dehydrogenase which catalyzes the second step of the proline degradation pathway, converting pyrroline-5-carboxylate to glutamate. Deficiency of this enzyme is associated with type II hyperprolinemia, an autosomal recessive disorder characterized by accumulation of delta-1-pyrroline-5-carboxylate (P5C) and proline. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2009]
ALDH4A1 Gene-Disease associations (from GenCC):
  • hyperprolinemia type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009564936).
BP6
Variant 1-18885513-G-A is Benign according to our data. Variant chr1-18885513-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 294391.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00237 (347/146580) while in subpopulation AFR AF = 0.004 (160/40034). AF 95% confidence interval is 0.00349. There are 1 homozygotes in GnomAd4. There are 151 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALDH4A1NM_003748.4 linkc.413C>T p.Pro138Leu missense_variant Exon 5 of 15 ENST00000375341.8 NP_003739.2 P30038-1A0A024RAC7
ALDH4A1NM_170726.3 linkc.413C>T p.Pro138Leu missense_variant Exon 5 of 16 NP_733844.1 P30038-1A0A024RAC7
ALDH4A1NM_001319218.2 linkc.413C>T p.Pro138Leu missense_variant Exon 5 of 14 NP_001306147.1 P30038-3
ALDH4A1NM_001161504.2 linkc.233C>T p.Pro78Leu missense_variant Exon 5 of 15 NP_001154976.1 P30038-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALDH4A1ENST00000375341.8 linkc.413C>T p.Pro138Leu missense_variant Exon 5 of 15 1 NM_003748.4 ENSP00000364490.3 P30038-1

Frequencies

GnomAD3 genomes
AF:
0.00237
AC:
347
AN:
146464
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00398
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000415
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000228
Gnomad FIN
AF:
0.000624
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00258
Gnomad OTH
AF:
0.00147
GnomAD2 exomes
AF:
0.00128
AC:
286
AN:
223664
AF XY:
0.00119
show subpopulations
Gnomad AFR exome
AF:
0.00272
Gnomad AMR exome
AF:
0.000217
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000913
Gnomad NFE exome
AF:
0.00214
Gnomad OTH exome
AF:
0.00177
GnomAD4 exome
AF:
0.00241
AC:
3359
AN:
1395434
Hom.:
4
Cov.:
37
AF XY:
0.00236
AC XY:
1637
AN XY:
692414
show subpopulations
African (AFR)
AF:
0.00285
AC:
90
AN:
31596
American (AMR)
AF:
0.000293
AC:
12
AN:
41002
Ashkenazi Jewish (ASJ)
AF:
0.0000418
AC:
1
AN:
23902
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35018
South Asian (SAS)
AF:
0.0000360
AC:
3
AN:
83380
European-Finnish (FIN)
AF:
0.00156
AC:
75
AN:
47940
Middle Eastern (MID)
AF:
0.000183
AC:
1
AN:
5460
European-Non Finnish (NFE)
AF:
0.00290
AC:
3105
AN:
1070962
Other (OTH)
AF:
0.00128
AC:
72
AN:
56174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
187
373
560
746
933
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00237
AC:
347
AN:
146580
Hom.:
1
Cov.:
31
AF XY:
0.00212
AC XY:
151
AN XY:
71220
show subpopulations
African (AFR)
AF:
0.00400
AC:
160
AN:
40034
American (AMR)
AF:
0.000415
AC:
6
AN:
14466
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3412
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4664
South Asian (SAS)
AF:
0.000228
AC:
1
AN:
4390
European-Finnish (FIN)
AF:
0.000624
AC:
6
AN:
9614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
286
European-Non Finnish (NFE)
AF:
0.00256
AC:
171
AN:
66752
Other (OTH)
AF:
0.00146
AC:
3
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
18
36
54
72
90
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00214
Hom.:
3
Bravo
AF:
0.00223
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.00142
AC:
172
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hyperprolinemia type 2 Uncertain:1Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability Uncertain:1
Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ALDH4A1: BP4 -

ALDH4A1-related disorder Benign:1
Dec 01, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.38
T;.;T;.;.
Eigen
Benign
0.14
Eigen_PC
Benign
0.053
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.90
.;D;D;D;D
MetaRNN
Benign
0.0096
T;T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.9
M;M;M;.;.
PhyloP100
6.2
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-2.7
D;D;D;D;D
REVEL
Benign
0.16
Sift
Uncertain
0.0050
D;D;D;D;D
Sift4G
Uncertain
0.011
D;T;D;T;.
Polyphen
0.96
D;.;D;.;.
Vest4
0.57
MVP
0.54
MPC
0.11
ClinPred
0.10
T
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.25
gMVP
0.57
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139640415; hg19: chr1-19212007; COSMIC: COSV99311564; COSMIC: COSV99311564; API